申请人:Burgey Christopher S.
公开号:US20110206783A1
公开(公告)日:2011-08-25
The subject invention relates to novel P2X
3
receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X
3
receptor subunit modulator.
本发明涉及一种新型P2X3受体拮抗剂,该拮抗剂在治疗与疼痛有关的疾病状态中发挥关键作用,特别是可以使用P2X3受体亚单位调节剂治疗的外周疼痛、炎症性疼痛或组织损伤疼痛。